{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:07:10Z","timestamp":1778594830991,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-408675\/2018-7"],"award-info":[{"award-number":["APQ-408675\/2018-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00436-020-06752-x","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T07:02:35Z","timestamp":1592031755000},"page":"2609-2622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells"],"prefix":"10.1007","volume":"119","author":[{"given":"Patr\u00edcia A. F.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora V. C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria R. S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethina T.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie C.","family":"Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S. V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo L. F.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Machado-de-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9014","authenticated-orcid":false,"given":"Eduardo A. F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,13]]},"reference":[{"key":"6752_CR1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3389\/fimmu.2018.02558","volume":"9","author":"MMC Abbehusen","year":"2018","unstructured":"Abbehusen MMC, Cunha J, Suarez MS, Teixeira C, Almeida VDA, Pereira LDS, Bordoni M, Gil-Santana L, Solc\u00e0 MDS, Fraga DBM, Fischer L, Bozza PT, Veras PST, Valenzuela JG, Kamhawi S, Andrade BB, Brodskyn CI (2018) Immunization of experimental dogs with salivary proteins from Lutzomyia longipalpis, using dna and recombinant canarypox virus induces immune responses consistent with protection against Leishmania infantum. Front Immunol 9:2558","journal-title":"Front Immunol"},{"key":"6752_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trivac.2015.11.001","volume":"5","author":"C Abeijon","year":"2016","unstructured":"Abeijon C, Daifalla N, Krautz-Peterson G, Pizzirani S, Beamer G, Frazatti-Gallina NM, Raw I, Campos-Neto A (2016) Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14 kDa Leishmania infantum recombinant polypeptide. Trials Vaccinol 5:1\u20137","journal-title":"Trials Vaccinol"},{"key":"6752_CR3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004468","volume":"10","author":"E Adem","year":"2016","unstructured":"Adem E, Tajebe F, Getahun M, Kiflie A, Diro E, Hailu A, Shkedy Z, Mengesha B, Mulaw T, Atnafu S, Deressa T, Mathewos B, Abate E, Modolell M, Munder M, M\u00fcller I, Takele Y, Kropf P (2016) Successful treatment of human visceral leishmaniasis restores antigen specific IFN-\u03b3, but not IL-10 production. PLoS Negl Trop Dis 10:e0004468","journal-title":"PLoS Negl Trop Dis"},{"key":"6752_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149894","volume":"11","author":"M Agallou","year":"2016","unstructured":"Agallou M, Athanasiou E, Samiotaki M, Panayotou G, Karagouni E (2016) Identification of immunoreactive Leishmania infantum protein antigens to asymptomatic dog sera through combined immunoproteomics and bioinformatics analysis. PLoS One 11:e0149894","journal-title":"PLoS One"},{"key":"6752_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","volume":"103","author":"M Agallou","year":"2018","unstructured":"Agallou M, Pantazi E, Tsiftsaki E, Toubanaki DK, Gaitanaki C, Smirlis D, Karagouni E (2018) Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides. Mol Immunol 103:7\u201320","journal-title":"Mol Immunol"},{"key":"6752_CR6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, Leishmaniasis Control Team WHO (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671","journal-title":"PLoS One"},{"key":"6752_CR7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","volume":"82","author":"A Amit","year":"2017","unstructured":"Amit A, Vijayamahantesh DMR, Singh AK, Kumar V, Suman SS, Singh A, Kumar A, Thakur AK, Das VR, Das P, Bimal S (2017) Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in BALB\/c mice. Mol Immunol 82:104\u2013113","journal-title":"Mol Immunol"},{"key":"6752_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2051013617741578","volume":"5","author":"A Askarizadeh","year":"2017","unstructured":"Askarizadeh A, Jaafari MR, Khamesipour A, Badiee A (2017) Liposomal adjuvant development for leishmaniasis vaccines. Ther Adv Vaccines 5:85\u2013101","journal-title":"Ther Adv Vaccines"},{"key":"6752_CR9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.exppara.2012.09.001","volume":"132","author":"A Badiee","year":"2012","unstructured":"Badiee A, Khamesipour A, Samiei A, Soroush D, Shargh VH, Kheiri MT, Barkhordari F, Robert Mc Master W, Mahboudi F, Jaafari MR (2012) The role of liposome size on the type of immune response induced in BALB\/c mice against leishmaniasis: rgp63 as a model antigen. Exp Parasitol 132:403\u2013409","journal-title":"Exp Parasitol"},{"key":"6752_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2012.11.068","volume":"31","author":"A Badiee","year":"2013","unstructured":"Badiee A, Heravi Shargh V, Khamesipour A, Jaafari MR (2013) Micro\/nanoparticle adjuvants for antileishmanial vaccines: present and future trends. Vaccine 31:735\u2013749","journal-title":"Vaccine"},{"key":"6752_CR11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","volume":"10","author":"C Bogdan","year":"2008","unstructured":"Bogdan C (2008) Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10:1221\u20131234","journal-title":"Cell Microbiol"},{"key":"6752_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2018.00381","volume":"8","author":"L Botana","year":"2018","unstructured":"Botana L, Mat\u00eda B, San Martin JV, Romero-Mat\u00e9 A, Castro A, Molina L, Fernandez L, Ibarra-Meneses A, Aguado M, S\u00e1nchez C, Horrillo L, Chicharro C, Nieto J, Ortega S, Ruiz-Giardin JM, Carrillo E, Moreno J (2018) Cellular markers of active disease and cure in different forms of Leishmania infantum-induced disease. Front Cell Infect Microbiol 8:381","journal-title":"Front Cell Infect Microbiol"},{"key":"6752_CR13","volume":"7","author":"RCF Brito","year":"2019","unstructured":"Brito RCF, Cardoso JMO, Reis LES, Mathias FAS, Aguiar-Soares RDO, Teixeira-Carvalho A, Roatt BM, Corr\u00eaa-Oliveira R, Ruiz JC, Resende DM, Reis AB (2019) Synthetic peptides elicit strong cellular immunity in visceral leishmaniasis natural reservoir and contribute to long-lasting polyfunctional T-cells in BALB\/c mice. Vaccines (Basel) 7:e162","journal-title":"Vaccines (Basel)"},{"key":"6752_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","volume":"5","author":"A Caldas","year":"2005","unstructured":"Caldas A, Favali C, Aquino D, Vinhas V, Van Weyenbergh J, Brodskyn C, Costa J, Barral-Netto M, Barral A (2005) Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5:113","journal-title":"BMC Infect Dis"},{"key":"6752_CR15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1006\/cyto.1995.0088","volume":"7","author":"E Cillari","year":"1995","unstructured":"Cillari E, Vitale G, Arcoleo F, D\u2019Agostino P, Mocciaro C, Gambino G, Malta R, Stassi G, Giordano C, Milano S, Mansueto S (1995) In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7:740\u2013745","journal-title":"Cytokine"},{"key":"6752_CR16","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","volume":"71","author":"EAF Coelho","year":"2003","unstructured":"Coelho EAF, Tavares CAP, Carvalho FAA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71:3988\u20133994","journal-title":"Infect Immun"},{"key":"6752_CR17","volume":"6","author":"VT Coelho","year":"2012","unstructured":"Coelho VT, Oliveira JS, Valadares DG, Ch\u00e1vez-Fumagalli MA, Duarte MC, Lage PS, Soto M, Santoro MM, Tavares CA, Fernandes AP, Coelho EA (2012) Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Negl Trop Dis 6:e1430","journal-title":"PLoS Negl Trop Dis"},{"key":"6752_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2015.6","volume":"4","author":"RN Coler","year":"2015","unstructured":"Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, Orr MT, Ashman J, Ghosh P, Mondal D, Reed SG (2015) From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE. Clin Transl Immunology 4:e35","journal-title":"Clin Transl Immunology"},{"key":"6752_CR19","doi-asserted-by":"crossref","first-page":"e110014","DOI":"10.1371\/journal.pone.0110014","volume":"9","author":"LE Costa","year":"2014","unstructured":"Costa LE, Goulart LR, Pereira NC, Lima MI, Duarte MC, Martins VT, Lage PS, Menezes-Souza D, Ribeiro TG, Melo MN, Fernandes AP, Soto M, Tavares CA, Ch\u00e1vez-Fumagalli MA, Coelho EA (2014) Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis. PLoS One 9:e110014","journal-title":"PLoS One"},{"key":"6752_CR20","doi-asserted-by":"crossref","first-page":"e1812","DOI":"10.3390\/ijms20081812","volume":"20","author":"LE Costa","year":"2019","unstructured":"Costa LE, Alves PT, Carneiro AP, Dias ACS, Fujimura PT, Araujo GR, Tavares GSV, Ramos FF, Duarte MC, Menezes-Souza D, Briza P, Briza FF, Coelho EAF, Goulart LR (2019) Leishmania infantum \u03b2-tubulin identified by reverse engineering technology through phage display applied as theranostic marker for human visceral leishmaniasis. Int J Mol Sci 20:e1812","journal-title":"Int J Mol Sci"},{"key":"6752_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micinf.2017.09.011","volume":"20","author":"P Das","year":"2018","unstructured":"Das P, Paik D, Naskar K, Chakraborti T (2018) Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis. Microbes Infect 20:37\u201347","journal-title":"Microbes Infect"},{"key":"6752_CR22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","volume":"10","author":"A Dayakar","year":"2019","unstructured":"Dayakar A, Chandrasekaran S, Kuchipudi SV, Kalangi SK (2019) Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy. Front Immunol 10:670","journal-title":"Front Immunol"},{"key":"6752_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2017.09.017","volume":"91","author":"DS Dias","year":"2017","unstructured":"Dias DS, Ribeiro PAF, Martins VT, Lage DP, Portela \u00c1SB, Costa LE, Salles BCS, Lima MP, Ramos FF, Santos TTO, Caligiorne RB, Ch\u00e1vez-Fumagalli MA, Silveira JAG, Magalh\u00e3es-Soares DF, Gon\u00e7alves DU, Oliveira JS, Roatt BM, Duarte MC, Menezes-Souza D, Silva ES, Galdino AS, Machado-de-\u00c1vila RA, Teixeira AL, Coelho EAF (2017) Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: potential vaccine and diagnostic application against visceral leishmaniasis. Mol Immunol 91:272\u2013281","journal-title":"Mol Immunol"},{"key":"6752_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","volume":"200","author":"DS Dias","year":"2018","unstructured":"Dias DS, Ribeiro PAF, Martins VT, Lage DP, Costa LE, Ch\u00e1vez-Fumagalli MA, Ramos FF, Santos TTO, Ludolf F, Oliveira JS, Mendes TAO, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF (2018a) Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis. Transl Res 200:18\u201334","journal-title":"Transl Res"},{"key":"6752_CR25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1017\/S0031182017001731","volume":"145","author":"DS Dias","year":"2018","unstructured":"Dias DS, Martins VT, Ribeiro PAF, Ramos FF, Lage DP, Tavares GSV, Mendon\u00e7a DVC, Ch\u00e1vez-Fumagalli MA, Oliveira JS, Silva ES, Gomes DA, Rodrigues MA, Duarte MC, Galdino AS, Menezes-Souza D, Coelho EAF (2018b) Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis. Parasitology 145:740\u2013751","journal-title":"Parasitology"},{"key":"6752_CR26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","volume":"22","author":"MC Duarte","year":"2015","unstructured":"Duarte MC, Pimenta DC, Menezes-Souza D, Magalh\u00e3es RD, Diniz JL, Costa LE, Ch\u00e1vez-Fumagalli MA, Lage PS, Bartholomeu DC, Alves MJ, Fernandes AP, Soto M, Tavares CA, Gon\u00e7alves DU, Rocha MO, Coelho EA (2015) Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis. Clin Vaccine Immunol 22:1187\u20131196","journal-title":"Clin Vaccine Immunol"},{"key":"6752_CR27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","volume":"49","author":"MC Duarte","year":"2016","unstructured":"Duarte MC, Lage DP, Martins VT, Ch\u00e1vez-Fumagalli MA, Roatt BM, Menezes-Souza D, Goulart LR, Soto M, Tavares CA, Coelho EA (2016) Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis. Rev Soc Bras Med Trop 49:398\u2013407","journal-title":"Rev Soc Bras Med Trop"},{"key":"6752_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","volume":"5","author":"S Gannavaram","year":"2014","unstructured":"Gannavaram S, Dey R, Avishek K, Selvapandiyan A, Salotra P, Nakhasi HL (2014) Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis - discovery and implications. Front Immunol 5:241","journal-title":"Front Immunol"},{"key":"6752_CR29","doi-asserted-by":"crossref","first-page":"e0117977","DOI":"10.1371\/journal.pone.0117977","volume":"10","author":"M Gatto","year":"2015","unstructured":"Gatto M, Abreu MM, Tasca KI, de Assis GM, da Silva LD, Sim\u00e3o JC, Fortaleza CM, de Campos Soares \u00c2M, Calvi SA (2015) The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs. PLoS One 10:e0117977","journal-title":"PLoS One"},{"key":"6752_CR30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","volume":"92","author":"HW Ghalib","year":"1993","unstructured":"Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, El-Hassan AM, Russo DM, Reed SG (1993) Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92:324\u2013329","journal-title":"J Clin Invest"},{"key":"6752_CR31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131\u2013138","journal-title":"Anal Biochem"},{"key":"6752_CR32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1590\/S0074-02762010000600015","volume":"105","author":"RF Grenfell","year":"2010","unstructured":"Grenfell RF, Marques-da-Silva EA, Souza-Testasicca MC, Coelho EA, Fernandes AP, Afonso LC, Rezende AS (2010) Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB\/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production. Mem Inst Oswaldo Cruz 105:818\u2013822","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6752_CR33","doi-asserted-by":"crossref","first-page":"e0185438","DOI":"10.1371\/journal.pone.0185438","volume":"12","author":"G Grimaldi Jr","year":"2017","unstructured":"Grimaldi G Jr, Teva A, Dos-Santos CB, Santos FN, Pinto ID, Fux B, Leite GR, Falqueto A (2017) Field trial of efficacy of the Leish-Tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates. PLoS One 12:e0185438","journal-title":"PLoS One"},{"key":"6752_CR34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","volume":"7","author":"SK Gupta","year":"2007","unstructured":"Gupta SK, Sisodia BS, Sinha S, Hajela K, Naik S, Shasany AK, Dube A (2007) Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes. Proteomics 7:816\u2013823","journal-title":"Proteomics"},{"key":"6752_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2011.558081","volume":"8","author":"M Henriksen-Lacey","year":"2011","unstructured":"Henriksen-Lacey M, Korsholm KS, Andersen P, Perrie Y, Christensen D (2011) Liposomal vaccine delivery systems. Expert Opin Drug Deliv 8:505\u2013519","journal-title":"Expert Opin Drug Deliv"},{"key":"6752_CR36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","volume":"7","author":"AV Ibarra-Meneses","year":"2017","unstructured":"Ibarra-Meneses AV, Ghosh P, Hossain F, Chowdhury R, Mondal D, Alvar J, Moreno J, Carrillo E (2017) IFN-\u03b3, IL-2, IP-10, and MIG as biomarkers of exposure to Leishmania spp., and of cure in human visceral leishmaniasis. Front cell infect Microbiol 7:200","journal-title":"Front cell infect Microbiol"},{"key":"6752_CR37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2019.00288","volume":"10","author":"S Joshi","year":"2019","unstructured":"Joshi S, Yadav NK, Rawat K, Kumar V, Ali R, Sahasrabuddhe AA, Siddiqi MI, Haq W, Sundar S, Dube A (2019) Immunogenicity and protective efficacy of T-cell epitopes derived from potential Th1 stimulatory proteins of Leishmania (Leishmania) donovani. Front Immunol 10:288","journal-title":"Front Immunol"},{"key":"6752_CR38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pim.12176","volume":"37","author":"H Kaur","year":"2015","unstructured":"Kaur H, Thakur A, Kaur S (2015) Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis. Parasite Immunol 37:192\u2013203","journal-title":"Parasite Immunol"},{"key":"6752_CR39","first-page":"1","volume":"30","author":"L Kedzierski","year":"2014","unstructured":"Kedzierski L, Evans KJ (2014) Immune responses during cutaneous and visceral leishmaniasis. Parasitology 30:1\u201319","journal-title":"Parasitology"},{"key":"6752_CR40","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2018.03.027","volume":"36","author":"YNK Keerti","year":"2018","unstructured":"Keerti YNK, Joshi S, Ratnapriya S, Sahasrabuddhe AA, Dube A (2018) Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis. Vaccine 36:2293\u20132299","journal-title":"Vaccine"},{"key":"6752_CR41","doi-asserted-by":"crossref","first-page":"9124326","DOI":"10.1155\/2019\/9124326","volume":"2019","author":"OS Koutsoni","year":"2019","unstructured":"Koutsoni OS, Barhoumi M, Guizani I, Dotsika E (2019) New insights on the adjuvant properties of the Leishmania infantum eukaryotic initiation factor. J Immunol Res 2019:9124326","journal-title":"J Immunol Res"},{"key":"6752_CR42","volume":"8","author":"R Kumar","year":"2014","unstructured":"Kumar R, Singh N, Gautam S, Singh OP, Gidwani K, Rai M, Sacks D, Sundar S, Nyl\u00e9n S (2014) Leishmania specific CD4 T cells release IFN-\u03b3 that limits parasite replication in patients with visceral leishmaniasis. PLoS Negl Trop Dis 8:e3198","journal-title":"PLoS Negl Trop Dis"},{"key":"6752_CR43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","volume":"37","author":"DP Lage","year":"2015","unstructured":"Lage DP, Martins VT, Duarte MC, Garde E, Ch\u00e1vez-Fumagalli MA, Menezes-Souza D, Roatt BM, Tavares CA, Soto M, Coelho EA (2015) Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis. Parasite Immunol 37:646\u2013656","journal-title":"Parasite Immunol"},{"key":"6752_CR44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.imbio.2019.05.008","volume":"224","author":"DP Lage","year":"2019","unstructured":"Lage DP, Machado AS, Ramos FF, Silveira PC, Dias DS, Ribeiro PAF, Tavares GSV, Costa LE, Santos TTO, Steiner BT, Fagundes MI, Ch\u00e1vez-Fumagalli MA, Lyon S, Moreira RLF, Duarte MC, Menezes-Souza D, Caligiorne RB, Machado-de-\u00c1vila RA, Teixeira AL, Coelho EAF (2019) A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein. Immunobiology 224:477\u2013484","journal-title":"Immunobiology"},{"key":"6752_CR45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetpar.2016.04.019","volume":"223","author":"BS Lima","year":"2016","unstructured":"Lima BS, Fialho LC Jr, Pires SF, Tafuri WL, Andrade HM (2016) Immunoproteomic and bioinformatic approaches to identify secreted Leishmania amazonensis, L. braziliensis, and L. infantum proteins with specific reactivity using canine serum. Vet Parasitol 223:115\u2013119","journal-title":"Vet Parasitol"},{"key":"6752_CR46","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","volume":"12","author":"M Margaroni","year":"2017","unstructured":"Margaroni M, Agallou M, Athanasiou E, Kammona O, Kiparissides C, Gaitanaki C, Karagouni E (2017) Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis. Int J Nanomedicine 12:6169\u20136184","journal-title":"Int J Nanomedicine"},{"key":"6752_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/427655ac-c278-41f5-95ca-6279c562752f","volume":"7","author":"VT Martins","year":"2013","unstructured":"Martins VT, Ch\u00e1vez-Fumagalli MA, Costa LE, Canavaci AM, Martins AM, Lage PS, Lage DP, Duarte MC, Valadares DG, Magalh\u00e3es RD, Ribeiro TG, Nagem RA, Darocha WD, R\u00e9gis WC, Soto M, Coelho EA, Fernandes AP, Tavares CA (2013) Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Negl Trop Dis 7:e2148","journal-title":"PLoS Negl Trop Dis"},{"key":"6752_CR48","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","volume":"39","author":"VT Martins","year":"2017","unstructured":"Martins VT, Duarte MC, Lage DP, Costa LE, Carvalho AM, Mendes TA, Roatt BM, Menezes-Souza D, Soto M, Coelho EA (2017) A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis. Parasite Immunol 39:e12359","journal-title":"Parasite Immunol"},{"key":"6752_CR49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.intimp.2018.03.012","volume":"59","author":"H Noormehr","year":"2018","unstructured":"Noormehr H, Zavaran Hosseini A, Soudi S, Beyzay F (2018) Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle. Int Immunopharmacol 59:97\u2013105","journal-title":"Int Immunopharmacol"},{"key":"6752_CR50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","volume":"14","author":"DT O\u2019Hagan","year":"2009","unstructured":"O\u2019Hagan DT, Gregorio E (2009) The path to a successful vaccine adjuvant: \"the long and winding road\". Drug Discov Today 14:541\u2013551","journal-title":"Drug Discov Today"},{"key":"6752_CR51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","volume":"62","author":"V Peruhype-Magalh\u00e3es","year":"2005","unstructured":"Peruhype-Magalh\u00e3es V, Martins-Filho OA, Prata A, Silva LA, Rabello A, Teixeira-Carvalho A, Figueiredo RM, Guimar\u00e3es-Carvalho SF, Ferrari TC, Correa-Oliveira R (2005) Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol 62:487\u2013495","journal-title":"Scand J Immunol"},{"key":"6752_CR52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky N, Aguilar JC (2004) Vaccine adjuvants: current state and future trends. Immunol Cell Biol 82:488\u2013496","journal-title":"Immunol Cell Biol"},{"key":"6752_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/sji.12557","volume":"86","author":"L Pirdel","year":"2017","unstructured":"Pirdel L, Farajnia S (2017) a non-pathogenic recombinant Leishmania expressing lipophosphoglycan 3 against experimental infection with Leishmania infantum. Scand J Immunol 86:15\u201322","journal-title":"Scand J Immunol"},{"key":"6752_CR54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.imbio.2017.10.043","volume":"223","author":"\u00c1SB Portela","year":"2018","unstructured":"Portela \u00c1SB, Costa LE, Salles BCS, Lima MP, Santos TTO, Ramos FF, Lage DP, Martins VT, Caligiorne RB, Lessa DR, Silva FR, Machado AS, Nascimento GF, Gama IS, Ch\u00e1vez-Fumagalli MA, Teixeira AL, Rocha MOC, Rocha RL, Coelho EAF (2018) Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis. Immunobiology 223:303\u2013309","journal-title":"Immunobiology"},{"key":"6752_CR55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","volume":"8","author":"ZI Rajput","year":"2007","unstructured":"Rajput ZI, Hu SH, Xiao CW, Arijo AG (2007) Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 8:153\u2013161","journal-title":"J Zhejiang Univ Sci B"},{"key":"6752_CR56","first-page":"e00101","volume":"4","author":"A Ramakrishnan","year":"2019","unstructured":"Ramakrishnan A, Schumack NM, Gariepy CL, Eggleston H, Nunez G, Espinoza N, Nieto M, Castillo R, Rojas J, McCoy AJ, Beck Z, Matyas GR, Alving CR, Guerry P, Poly F, Laird RM (2019) Enhanced immunogenicity and protective efficacy of a Campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid a and QS-21. mSphere 4:e00101","journal-title":"mSphere"},{"key":"6752_CR57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2012.00144","volume":"3","author":"VS Raman","year":"2012","unstructured":"Raman VS, Duthie MS, Fox CB, Matlashewski G, Reed SG (2012) Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol 3:144","journal-title":"Front Immunol"},{"key":"6752_CR58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s13071-017-2576-8","volume":"10","author":"FF Ramos","year":"2017","unstructured":"Ramos FF, Costa LE, Dias DS, Santos TTO, Rodrigues MR, Lage DP, Salles BCS, Martins VT, Ribeiro PAF, Ch\u00e1vez-Fumagalli MA, Dias ACS, Alves PT, Vieira \u00c9LM, Roatt BM, Menezes-Souza D, Duarte MC, Teixeira AL, Goulart LR, Coelho EAF (2017) Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection. Parasit Vectors 10:617","journal-title":"Parasit Vectors"},{"key":"6752_CR59","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/infdis\/jiy348","volume":"218","author":"M Rao","year":"2018","unstructured":"Rao M, Onkar S, Peachman KK, White Y, Trinh HV, Jobe O, Zhou Y, Dawson P, Eller MA, Matyas GR, Alving CR (2018) Liposome-encapsulated human immunodeficiency virus-1 gp120 induces potent V1V2-specific antibodies in humans. J Infect Dis 218:1541\u20131550","journal-title":"J Infect Dis"},{"key":"6752_CR60","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","volume":"37","author":"S Ratnapriya","year":"2019","unstructured":"Ratnapriya S, Keerti SAA, Dube A (2019) Visceral leishmaniasis: an overview of vaccine adjuvants and their applications. Vaccine 37:3505\u20133519","journal-title":"Vaccine"},{"key":"6752_CR61","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2011.07.041","volume":"29","author":"J Rey-Ladino","year":"2011","unstructured":"Rey-Ladino J, Ross AG, Cripps AW, McManus DP, Quinn R (2011) Natural products and the search for novel vaccine adjuvants. Vaccine 29:6464\u20136471","journal-title":"Vaccine"},{"key":"6752_CR62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2018.08.019","volume":"111","author":"PAF Ribeiro","year":"2018","unstructured":"Ribeiro PAF, Dias DS, Novais MVM, Lage DP, Tavares GSV, Mendon\u00e7a DVC, Oliveira JS, Ch\u00e1vez-Fumagalli MA, Roatt BM, Duarte MC, Menezes-Souza D, Ludolf F, Tavares CAP, Oliveira MC, Coelho EAF (2018a) A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis. Cytokine 111:131\u2013139","journal-title":"Cytokine"},{"key":"6752_CR63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diagmicrobio.2018.05.026","volume":"92","author":"PAF Ribeiro","year":"2018","unstructured":"Ribeiro PAF, Dias DS, Lage DP, Costa LE, Salles BCS, Steiner BT, Ramos FF, Lima MP, Santos TTO, Chaves AT, Ch\u00e1vez-Fumagalli MA, Fujiwara RT, Bueno LL, Caligiorne RB, Magalh\u00e3es-Soares DF, Silveira JAG, Machado-de-\u00c1vila RA, Gon\u00e7alves DU, Coelho EAF (2018b) A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up. Diagn Microbiol Infect Dis 92:196\u2013203","journal-title":"Diagn Microbiol Infect Dis"},{"key":"6752_CR64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","volume":"106","author":"PAF Ribeiro","year":"2019","unstructured":"Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, DVC M, Ludolf F, Gomes DA, Rodrigues MA, Ch\u00e1vez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF (2019) Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection. Mol Immunol 106:108\u2013118","journal-title":"Mol Immunol"},{"key":"6752_CR65","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","volume":"56","author":"S Rijal","year":"2013","unstructured":"Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo T, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC (2013) Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56:1530\u20131538","journal-title":"Clin Infect Dis"},{"key":"6752_CR66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2016.07.011","volume":"309","author":"A Sabur","year":"2016","unstructured":"Sabur A, Asad M, Ali N (2016) Lipid based delivery and immuno-stimulatory systems: master tools to combat leishmaniasis. Cell Immunol 309:55\u201360","journal-title":"Cell Immunol"},{"key":"6752_CR67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","volume":"9","author":"A Sabur","year":"2018","unstructured":"Sabur A, Bhowmick S, Chhajer R, Ejazi SA, Didwania N, Asad M, Bhattacharyya A, Sinha U, Ali N (2018) Lipossomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis. Front Immunol 9:18","journal-title":"Front Immunol"},{"key":"6752_CR68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.actatropica.2017.03.008","volume":"171","author":"TTO Santos","year":"2017","unstructured":"Santos TTO, Martins VT, Lage DP, Costa LE, Salles BCS, Carvalho AMRS, Dias DS, Ribeiro PAF, Ch\u00e1vez-Fumagalli MA, Machado-de-\u00c1vila RA, Roatt BM, de Magalh\u00e3es-Soares DF, Menezes-Souza D, Coelho EAF, Duarte MC (2017) Probing the efficacy of a heterologous Leishmania Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB\/c mice. Acta Trop 171:8\u201316","journal-title":"Acta Trop"},{"key":"6752_CR69","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2016.09.016","volume":"34","author":"RG Schaut","year":"2016","unstructured":"Schaut RG, Grinnage-Pulley TL, Esch KJ, Toepp AJ, Duthie MS, Howard RF, Reed SG, Petersen CA (2016) Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant. Vaccine 34:5225\u20135234","journal-title":"Vaccine"},{"key":"6752_CR70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001874","volume":"6","author":"OP Singh","year":"2012","unstructured":"Singh OP, Stober CB, Singh AK, Blackwell JM, Sundar S (2012) Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 6:e1874","journal-title":"PLoS Negl Trop Dis"},{"key":"6752_CR71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2017.02.008","volume":"85","author":"N Singh","year":"2017","unstructured":"Singh N, Sundar S (2017) Inflammatory chemokines and their receptors in human visceral leishmaniasis: gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells. Mol Immunol 85:111\u2013119","journal-title":"Mol Immunol"},{"key":"6752_CR72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2013.02.004","volume":"57","author":"MA Souza","year":"2013","unstructured":"Souza MA, Castro MC, Oliveira AP, Almeida AF, Almeida TM, Reis LC, Medeiros \u00c2C, Brito ME, Pereira VR (2013) Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals. Microb Pathog 57:27\u201332","journal-title":"Microb Pathog"},{"key":"6752_CR73","first-page":"98","volume":"3","author":"S Sundar","year":"2016","unstructured":"Sundar S, Singh A (2016) Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther Adv Infect Dis 3:98\u2013109","journal-title":"Ther Adv Infect Dis"},{"key":"6752_CR74","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","volume":"220","author":"A Thakur","year":"2015","unstructured":"Thakur A, Kaur H, Kaur S (2015) Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice. Immunobiology 220:1031\u20131038","journal-title":"Immunobiology"},{"key":"6752_CR75","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","volume":"19","author":"AA Vijayamahantesh","year":"2017","unstructured":"Vijayamahantesh AA, Dikhit MR, Singh AK, Venkateshwaran T, Das VNR, Das P, Bimal S (2017) Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects. Microbes Infect 19:358\u2013369","journal-title":"Microbes Infect"},{"key":"6752_CR76","unstructured":"World Health Organization. (2018) Leishmaniasis. http:\/\/www.who.int\/topics\/leishmaniasis\/en\/"},{"key":"6752_CR77","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/21645515.2016.1264547","volume":"13","author":"PF Wowk","year":"2017","unstructured":"Wowk PF, Franco LH, Fonseca DMD, Paula MO, Vianna \u00c9DSO, Wendling AP, Augusto VM, El\u00f3i-Santos SM, Teixeira-Carvalho A, Silva FDC, Vinhas SA, Martins-Filho OA, Palaci M, Silva CL, Bonato VLD (2017) Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients. Hum Vaccin Immunother 13:1040\u20131050","journal-title":"Hum Vaccin Immunother"},{"key":"6752_CR78","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.2147\/IJN.S207589","volume":"14","author":"J Ye","year":"2019","unstructured":"Ye J, Yang Y, Dong W, Gao Y, Meng Y, Wang H, Li L, Jin J, Ji M, Xia X, Chen X, Jin Y, Liu Y (2019) Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages. Int J Nanomedicine 14:3203\u20133220","journal-title":"Int J Nanomedicine"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06752-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-020-06752-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06752-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T23:29:33Z","timestamp":1623540573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-020-06752-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,13]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["6752"],"URL":"https:\/\/doi.org\/10.1007\/s00436-020-06752-x","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,13]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}